reports
- Jonathan Moreland
TBK TRIUMPH BANCORP INC.
NEOG NEOGEN CORPORATION
LAKE LAKELAND INDUSTRIES INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
ALOT ASTRONOVA INC.
IIFw MORGAN STANLEY INDIA INVESTMENT FUND INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
PASG PASSAGE BIO
RLAY INC.
CTGO RELAY THERAPEUTICS
TEAF CONTANGO ORE INC.
PROK ECOFIN SUSTAINABLE AND SOCIAL IMPACT TERM FUND
MIO PROKIDNEY CORP.
DMA PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
ADVM DESTRA MULTI ALTERNATIVE FUND
GF ADVERUM BIOTECHNOLOGIES INC.
THE NEW GERMANY FUND
INC.
- Jonathan Moreland
ORCL ORACLE CORPORATION
NEOG NEOGEN CORPORATION
KEY KEYCORP
FLWS 1-800-FLOWERS.COM CL A
RCII RENT-A-CENTER INC
ESQ ESQUIRE FINANCIAL HOLDINGS
MCFT MASTERCRAFT BOAT HOLDINGS
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
PKE PARK AEROSPACE CORPORATION
ALLY GMAC LLC
UAN CVR PARTNERS LP
BYRN BYRNA TECHNOLOGIES INC
BTMD HAYMAKER ACQUISITION CORP III
GTE GRAN TIERRA ENERGY INC.
CVI CVR ENERGY
BATRK INC.
LIBERTY MEDIA CORPORATION
Texas Capital Bancshares, Inc. Appoints Ranjana B. Clark to Board of D...
Texas Capital Bancshares, Inc. Appoints Ranjana B. Clark to Board of Directors DALLAS, April 22, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today announced the appointment of Ranjana B. Clark to its Board of Directors, effective April 15, 2025. Clark will serve as a member of the Audit and Technology Committees. Clark has over 35 years of executive experience in the financial services and technology industries, with previous leadership roles spanning payments, marketing, strategy and business operations. Most recently, sh...
Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Prefer...
Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock DALLAS, April 21, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, and its board of directors declared a cash dividend of $14.375 per share of the 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), equivalent to $0.359375 per depositary share, each representing a 1/40th interest in a share of the Series B Preferred Stock. The depositary shares are traded on the NASDAQ under the symbol “TCBIO.” Th...
Texas Capital Bancshares, Inc. Announces First Quarter 2025 Results
Texas Capital Bancshares, Inc. Announces First Quarter 2025 Results First quarter 2025 net income of $47.0 million and net income available to common stockholders of $42.7 million, or $0.92 per diluted share Strong balance sheet growth with total deposits increasing 9% and total loans growing 7% year-over-year Book Value and Tangible Book Value(1) per share both increasing 11% year-over-year, reaching record levels Capital ratios continue to be strong, including 11.6% CET1 and 15.6% Total Capital DALLAS, April 17, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI),...
Texas Capital President & Chief Executive Officer Rob C. Holmes Now Se...
Texas Capital President & Chief Executive Officer Rob C. Holmes Now Serves as Chairman of the Board DALLAS, April 15, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today announced that President & Chief Executive Officer Rob C. Holmes was confirmed as Chairman of the Board of Directors at the conclusion of TCBI’s 2025 Annual Meeting of Stockholders. Holmes, who has served as President & Chief Executive Officer and a Director of the Board since 2021, was to this position by the Board of Directors in January 2025. Bob Stalling...
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chi...
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial hypertension (“PAH”), today announced the appointment of David McIntyre as Chief Financial Officer, effective April 14, 2025. “David has extensive experience in financial strategy and corporate governance, as well as an established reputation within t...
- Jonathan Moreland
PBF PBF ENERGY INC. CLASS A
OMI OWENS & MINOR INC.
MOD MODINE MANUFACTURING COMPANY
CMC COMMERCIAL METALS COMPANY
ALDX ALDEYRA THERAPEUTICS
KYN KAYNE ANDERSON MLP INVESTMENT CO.
JELD JELD-WEN HOLDING INC.
NHF NEXPOINT CREDIT STRATEGIES FUN
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
ZYME ZYMEWORKS INC.
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
LPI LAREDO PETROLEUM INC.
ASAN ASANA
PCVX VAXCYTE
UAN CVR PARTNERS LP
ZIP ZIPRECRUITER
PFBX INC.
BTMD PEOPLES FINANCIAL CORP. (MISSISSIPPI)
TEAF HAYMAKER ACQUISITION CORP III
GLSI ECOFIN SUSTAINABLE AND SOCIAL IMPACT TERM FUND
MEGI GREENWICH LIFESCIENCES INC
NMTC MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
SBGI NEUROONE MEDICAL TECHNOLOGIES CORP
CVI SINCLAIR INC
NYC CVR ENERGY
EU INC.
ECF NEW YORK CITY REIT
INC.
WISDOMTREE EURO DEBT FUND
ELLSWORTH FUND LTD
Texas Capital Bancshares, Inc. Announces Date for Q1 2025 Operating Re...
Texas Capital Bancshares, Inc. Announces Date for Q1 2025 Operating Results DALLAS, April 03, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the first quarter of 2025 before market on Thursday, April 17, 2025. Executive management will host a conference call and webcast to discuss first quarter 2025 operating results on Thursday, April 17, 2025, at 9:00 a.m. EDT. Participants may pre-register for the call by visiting and will receive a unique PIN number to ...
Inhibikase Therapeutics Announces 2024 Financial Results and Highlight...
Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity New Leadership and Focus on Advancement of IkT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial Hypertension BOSTON, March 27, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial hypertension (“PAH”), today reported financial results for the year ended December 31, 2024 and highlighted recent developments. “The fin...
- Jonathan Moreland
TDOC TELADOC HEALTH INC.
PSEC PROSPECT CAPITAL CORPORATION
ORRF ORRSTOWN FINANCIAL SERVICES INC.
ADBE ADOBE INC.
ECC EAGLE POINT CREDIT CO INC
TCPC BLACKROCK TCP CAPITAL CORP.
AEYE AUDIOEYE INC
ZIP ZIPRECRUITER
ECAT INC.
BUKS BLACKROCK ESG CAP ALLOCATION TR
SBGI BUTLER NATIONAL CORP
SINCLAIR INC
- Jonathan Moreland
AAON AAON INC.
TTSH TILE SHOP HOLDINGS INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
I3N CHART INDUSTRIES INC.
CDXS CODEXIS
APLE APPLE HOSPITALITY REIT INC
TDW TIDEWATER INC
RC GRUPO RADIO CENTRO S.A.B. DE C.V.
ONEW ONEWATER MARINE
CMTG CLAROS MORTGAGE TRUST
CLVT INC.
VSCO CLARIVATE PLC
MCVT VICTORIA'S SECRET & CO
ECAT MILL CITY VENTURES III LTD
SBGI BLACKROCK ESG CAP ALLOCATION TR
DK SINCLAIR INC
CUBA DELEK US HOLDINGS
VG INC.
FDBC THE HERZFELD CARIBBEAN BASIN FUND
INC.
VENTURE GLOBAL INC.
FIDELITY D & D BANCORP INC
Inhibikase Announces Expansion of Senior Leadership Team
Inhibikase Announces Expansion of Senior Leadership Team --- Chris Cabell, MD MHS FACC Appointed President and Head of Research & Development --- --- John Adams, PhD Appointed Chief Scientific Officer --- --- Vince Aurentz to join Inhibikase Board of Directors --- BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced the appointment of two pharma industry executives with deep experience in pulmonary arterial hypertension (“PAH”) to its senior leadership team. Chris Cabell, M.D., former Chief Medical Off...
Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next ...
Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth -- Mr. Iwicki Brings Track Record of Operational Excellence and Significant Expertise in PAH and Cardiovascular Diseases -- -- Amit Munshi Appointed Chair of the Board of Directors -- BOSTON, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced the appointment of Mark Iwicki as the Company's Chief Executive Officer, replacing Dr. Milton H. Werner, founder of Inhibikase, effective February 14, 2025. Additionally,...
Texas Capital Recognized with Notable Industry Awards
Texas Capital Recognized with Notable Industry Awards DALLAS, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, begins the year with notable awards from Bankrate, GOBankingRates and Newsweek recognizing its excellence in financial services. These accolades highlight the firm’s commitment to providing clients with top-tier financial products and solutions, strengthening the company’s position as the premier full-service financial services firm headquartered in Texas. Key Highlights Bankrate – Best Regional Bank (Two ...
- Jonathan Moreland
XNCR XENCOR INC.
RLI RLI CORP.
PBF PBF ENERGY INC. CLASS A
ORRF ORRSTOWN FINANCIAL SERVICES INC.
NEOG NEOGEN CORPORATION
MKL MARKEL CORPORATION
LAKE LAKELAND INDUSTRIES INC.
JBLU JETBLUE AIRWAYS CORPORATION
EL ESTEE LAUDER COMPANIES INC. CLASS A
CTSO CYTOSORBENTS
BUSE FIRST BUSEY CORPORATION
BAH BOOZ ALLEN HAMILTON HOLDING CORPORATION CLASS A
CBFV CB FINANCIAL SERVICES INC.
MUR MURPHY OIL CORPORATION
OLN OLIN CORPORATION
WVE WAVE LIFE SCIENCES
OVLY OAK VALLEY BANCORP
FLWS 1-800-FLOWERS.COM CL A
KALV KALVISTA PHARMACEUTICALS
ANAB ANAPTYSBIO INC.
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
MPB MID PENN BANCORP INC.
CIK CREDIT SUISSE ASSET MANAGEMENT INCOME FUND INC.
COGT COGINT
NWFL INC.
FRAF NORWOOD FINANCIAL CORP.
ETST FRANKLIN FINANCIAL SERVICES CO.
LOOP EARTH SCIENCE TECH
ANIX LOOP INDUSTRIES
MFON ANIXA BIOSCIENCES
PNTG MOBIVITY HOLDINGS CORP.
ZYME PENNANT GROUP
PLCE ZYMEWORKS INC.
ALLY THE CHILDREN'S PLACE RETAIL STORES
IMNM INC.
CTOS GMAC LLC
IBRX IMMUNOME
BHRB CUSTOM TRUCK ONE SOURCE
VGAS INC.
TLSI IMMUNITYBIO INC
TKO BURKE & HERBERT BANK & TR/VA
PCSA VERDE CLEAN FUELS INC
PROP TRISALUS LIFE SCIENCES INC
MIO TKO GROUP HOLDINGS
MXF INC.
SUNS PROCESSA PHARMACEUTICALS INC
BATRK PRAIRIE OPERATING CO.
MYCB PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
THE MEXICO FUND
INC.
SUNRISE REALTY TRUST
LIBERTY MEDIA CORPORATION
MY CITY BUILDERS
INC.
- Jonathan Moreland
RLI RLI CORP.
NEOG NEOGEN CORPORATION
LNDC LANDEC CORP.
LAKE LAKELAND INDUSTRIES INC.
CTSO CYTOSORBENTS
ASA ASA
WVE WAVE LIFE SCIENCES
OVLY OAK VALLEY BANCORP
FLWS 1-800-FLOWERS.COM CL A
FBK FB FINANCIAL CORPORATION
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ESQ ESQUIRE FINANCIAL HOLDINGS
MPB MID PENN BANCORP INC.
CIK CREDIT SUISSE ASSET MANAGEMENT INCOME FUND INC.
COGT COGINT
ETST INC.
LOOP EARTH SCIENCE TECH
FUND LOOP INDUSTRIES
ANIX ROYCE FOCUS TRUST
LBSRD INC.
ETON ANIXA BIOSCIENCES
GRX LIBERTY STAR URANIUM & METALS
MFON ETON PHARMACEUTICALS
PNTG THE GABELLI HEALTHCARE & WELLNESSRX TRUST
ZYME MOBIVITY HOLDINGS CORP.
ALLY PENNANT GROUP
ENX ZYMEWORKS INC.
IBRX GMAC LLC
ACXP EATON VANCE NEW YORK MUNICIPAL BOND FUND
CVI IMMUNITYBIO INC
TLSI ACURX PHARMACEUTICALS INC
PCSA CVR ENERGY
PROP INC.
AVDL TRISALUS LIFE SCIENCES INC
MIO PROCESSA PHARMACEUTICALS INC
MXF PRAIRIE OPERATING CO.
SUNS AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY
TXO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
AMST THE MEXICO FUND
WHLM INC.
IBIO SUNRISE REALTY TRUST
SDHY MORNINGSTAR PARTNERS
BATRK L.P.
MYCB AMESITE INC.
WILHELMINA INTERNATIONAL INC
IBIO INC.
PGIM SHORT DURATION HIGH YIELD OPPORTUNITIES FUND
LIBERTY MEDIA CORPORATION
MY CITY BUILDERS
INC.
- Jonathan Moreland
OPK OPKO HEALTH INC.
NEOG NEOGEN CORPORATION
LNDC LANDEC CORP.
LAKE LAKELAND INDUSTRIES INC.
CTSO CYTOSORBENTS
FRD FRIEDMAN INDUSTRIES INC.
ESQ ESQUIRE FINANCIAL HOLDINGS
MPB MID PENN BANCORP INC.
ETST EARTH SCIENCE TECH
ANIX ANIXA BIOSCIENCES
LBSRD LIBERTY STAR URANIUM & METALS
ALLY GMAC LLC
ACXP ACURX PHARMACEUTICALS INC
GLSI GREENWICH LIFESCIENCES INC
TLSI TRISALUS LIFE SCIENCES INC
PCSA PROCESSA PHARMACEUTICALS INC
MXF THE MEXICO FUND
AMST INC.
MYCB AMESITE INC.
MY CITY BUILDERS
INC.
Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Prefer...
Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock DALLAS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, and its board of directors declared a cash dividend of $14.375 per share of the 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), equivalent to $0.359375 per depositary share, each representing a 1/40th interest in a share of the Series B Preferred Stock. The depositary shares are traded on the NASDAQ under the symbol “TCBIO.” The...
- Jonathan Moreland
NEOG NEOGEN CORPORATION
LAKE LAKELAND INDUSTRIES INC.
CTSO CYTOSORBENTS
CDXS CODEXIS
ASA ASA
ADC AGREE REALTY CORPORATION
WVE WAVE LIFE SCIENCES
FBK FB FINANCIAL CORPORATION
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
DMLP DORCHESTER MINERALS L.P.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
CIK CREDIT SUISSE ASSET MANAGEMENT INCOME FUND INC.
COGT COGINT
ZIVO INC.
ETST ZIVO BIOSCIENCE
FUND INC.
ANIX EARTH SCIENCE TECH
LBSRD ROYCE FOCUS TRUST
ETON INC.
GRX ANIXA BIOSCIENCES
MCFT LIBERTY STAR URANIUM & METALS
PGNY ETON PHARMACEUTICALS
PNTG THE GABELLI HEALTHCARE & WELLNESSRX TRUST
DCTH MASTERCRAFT BOAT HOLDINGS
ENX PROGYNY
PRLD PENNANT GROUP
NVCT DELCATH SYSTEMS
ANEB EATON VANCE NEW YORK MUNICIPAL BOND FUND
IBRX PRELUDE THERAPEUTICS
BHVN NUVECTIS PHARMA INC
ACXP ANEBULO PHARMACEUTICALS INC
BUKS IMMUNITYBIO INC
GLSI BIOHAVEN LTD
MEGI ACURX PHARMACEUTICALS INC
CVI BUTLER NATIONAL CORP
SRFM GREENWICH LIFESCIENCES INC
OCX MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
AVDL CVR ENERGY
MXF INC.
TXO SURF AIR MOBILITY INC.
TTGT ONCOCYTE CORPORATION
AMST AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY
WHLM THE MEXICO FUND
IBIO INC.
SDHY MORNINGSTAR PARTNERS
BATRK L.P.
MYCB TECHTARGET INC.
AMESITE INC.
WILHELMINA INTERNATIONAL INC
IBIO INC.
PGIM SHORT DURATION HIGH YIELD OPPORTUNITIES FUND
LIBERTY MEDIA CORPORATION
MY CITY BUILDERS
INC.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.